NASDAQ:ONEM
One Medical
- Stock
Last Close
16.47
21/02 21:00
Market Cap
3.40B
Beta: -
Volume Today
15.27M
Avg: 2.43M
PE Ratio
−8.48
PFCF: −11.91
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|
average inventory | 3.96M - | 3.52M 11.14% | 5.15M 46.32% | 6.59M 27.88% | 7.00M 6.31% | ||
average payables | 4.41M - | 9.58M 117.29% | 13.25M 38.28% | 15.69M 18.38% | 16.94M 7.95% | ||
average receivables | 13.99M - | 23.21M 65.94% | 49.17M 111.84% | 85.70M 74.27% | 120.43M 40.53% | ||
book value per share | -1.20 - | -1.66 39.12% | -1.53 8.09% | 4.63 403.18% | 11.25 142.74% | 7.84 30.33% | |
capex per share | -0.13 - | -0.12 12.37% | -0.44 278.42% | -0.54 21.07% | -0.41 23.09% | -0.37 9.61% | |
capex to depreciation | -1.31 - | -1.08 17.52% | -2.22 105.15% | -2.85 28.23% | -1.37 51.95% | -0.81 40.91% | |
capex to operating cash flow | 5.16 - | 0.58 88.67% | 1.72 193.73% | 17.73 931.87% | 0.72 95.95% | 0.35 51.54% | |
capex to revenue | -0.08 - | -0.05 36.19% | -0.20 289.04% | -0.17 14.93% | -0.10 38.91% | -0.07 31.11% | |
cash per share | 0.41 - | 2.52 515.07% | 1.20 52.41% | 5.77 381.97% | 2.95 48.84% | 1.33 54.88% | |
days of inventory on hand | 12.32 - | 10.32 16.24% | 6.95 32.66% | 11.05 58.97% | 5.09 53.96% | 3.37 33.81% | |
days payables outstanding | 10.60 - | 14.25 34.40% | 30.17 111.71% | 19.66 34.84% | 15.71 20.11% | 6.42 59.12% | |
days sales outstanding | 24.79 - | 27.41 10.56% | 40.24 46.80% | 65.18 61.98% | 60.78 6.75% | 47.95 21.10% | |
debt to assets | 1.90 - | 1.45 23.62% | 1.43 1.61% | 0.49 65.90% | 0.34 29.90% | 0.37 6.82% | |
debt to equity | -2.02 - | -3.11 54.32% | -3.27 4.93% | 0.95 129.16% | 0.52 45.44% | 0.58 10.75% | |
dividend yield | |||||||
earnings yield | -0.01 - | -0.02 64.61% | -0.02 11.40% | -0.02 11.74% | -0.09 449.21% | -0.12 28.14% | |
enterprise value | 2.30B - | 1.99B 13.43% | 2.81B 40.96% | 5.30B 88.53% | 2.97B 43.97% | 3.72B 25.45% | |
enterprise value over ebitda | -120.27 - | -59.27 50.71% | -102.24 72.49% | -99.92 2.27% | -15.13 84.85% | -11.41 24.61% | |
ev to operating cash flow | -847.40 - | -108.31 87.22% | -88.73 18.07% | -1.47K 1,561.52% | -33.52 97.73% | -17.59 47.54% | |
ev to sales | 13.03 - | 9.38 28.05% | 10.17 8.52% | 13.94 36.98% | 4.78 65.72% | 3.56 25.42% | |
free cash flow per share | -0.16 - | -0.32 98.91% | -0.70 120.94% | -0.57 19.16% | -0.99 74.16% | -1.45 46.35% | |
free cash flow yield | -0.01 - | -0.01 98.91% | -0.03 120.94% | -0.01 59.13% | -0.06 332.67% | -0.09 53.88% | |
graham net net | -1.90 - | -2.51 32.33% | -3.60 43.26% | 1.82 150.50% | -2.37 230.47% | -2.64 11.24% | |
graham number | 2.81 - | 4.26 51.33% | 3.84 9.76% | 8.84 130.05% | 20.48 131.65% | 18.87 7.85% | |
income quality | 0.09 - | 0.41 369.66% | 0.60 45.40% | 0.04 93.28% | 0.35 758.55% | 0.53 53.07% | |
intangibles to total assets | 0.17 - | 0.07 60.06% | 0.05 24.60% | 0.02 60.16% | 0.57 2,770.13% | 0.60 5.82% | |
interest coverage | -38.08 - | -56.03 47.13% | -114.16 103.76% | -5.31 95.35% | -17.70 233.20% | -35.93 103.01% | |
interest debt per share | 0.08 - | 0.04 44.86% | 0.00 91.13% | 2.18 56,173.11% | 4.06 86.43% | 3.35 17.62% | |
inventory turnover | 29.62 - | 35.36 19.38% | 52.51 48.50% | 33.03 37.10% | 71.75 117.22% | 108.40 51.08% | |
invested capital | -0.06 - | -0.02 64.78% | 0.45 - | 0.35 20.76% | 0.42 18.76% | ||
market cap | 2.31B - | 2.02B 12.39% | 2.70B 33.54% | 5.17B 91.27% | 2.70B 47.74% | 3.29B 21.93% | |
net current asset value | -187.35M - | -218.22M 16.48% | -414.29M 89.85% | 252.18M 160.87% | -285.42M 213.18% | -437.81M 53.39% | |
net debt to ebitda | 0.30 - | 0.86 186.37% | -3.96 558.30% | -2.48 37.42% | -1.37 44.79% | -1.32 3.31% | |
net income per share | -0.29 - | -0.48 64.61% | -0.43 11.40% | -0.75 74.56% | -1.66 121.07% | -2.02 21.87% | |
operating cash flow per share | -0.03 - | -0.20 673.09% | -0.26 28.83% | -0.03 88.27% | -0.58 1,797.98% | -1.07 86.54% | |
payables turnover | 34.43 - | 25.62 25.59% | 12.10 52.77% | 18.57 53.46% | 23.24 25.17% | 56.85 144.61% | |
receivables turnover | 14.72 - | 13.32 9.56% | 9.07 31.88% | 5.60 38.26% | 6.01 7.24% | 7.61 26.75% | |
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.28 - | -0.15 47.68% | -0.13 11.16% | -0.08 34.74% | -0.23 167.24% | -0.41 82.88% | |
revenue per share | 1.69 - | 2.32 37.32% | 2.26 2.73% | 3.21 42.32% | 4.04 25.90% | 5.31 31.21% | |
roe | 0.25 - | 0.29 18.32% | 0.28 3.59% | -0.16 157.58% | -0.15 8.93% | -0.26 74.92% | |
roic | -0.33 - | -0.18 45.24% | -0.15 16.94% | -0.09 43.37% | -0.13 46.76% | -0.20 55.80% | |
sales general and administrative to revenue | 0.33 - | 0.40 23.04% | 0.39 2.24% | 0.41 4.87% | 0.52 25.68% | 0.40 23.50% | |
shareholders equity per share | -1.20 - | -1.66 39.12% | -1.53 8.09% | 4.63 403.18% | 11.25 142.74% | 7.84 30.33% | |
stock based compensation to revenue | 0.05 - | 0.07 21.59% | 0.05 17.85% | 0.09 71.40% | 0.18 95.74% | 0.14 22.23% | |
tangible asset value | -141.75M - | -169.84M 19.82% | -205.35M 20.91% | 527.17M 356.71% | 228.96M 56.57% | 74.41M 67.50% | |
tangible book value per share | -1.35 - | -1.85 36.76% | -1.68 9.46% | 4.45 365.46% | 1.49 66.55% | 0.38 74.65% | |
working capital | 19.96M - | 202.80M 916.09% | 116.56M 42.53% | 657.27M 463.91% | 410.92M 37.48% | 246.26M 40.07% |
All numbers in USD (except ratios and percentages)